L. Bauer

505 total citations
10 papers, 251 citations indexed

About

L. Bauer is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, L. Bauer has authored 10 papers receiving a total of 251 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in L. Bauer's work include Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (3 papers) and Neutropenia and Cancer Infections (2 papers). L. Bauer is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (3 papers) and Neutropenia and Cancer Infections (2 papers). L. Bauer collaborates with scholars based in United States. L. Bauer's co-authors include Ronald M. Bukowski, G. Thomas Budd, James K. Weick, J. Sergi, James M. Boyett, P M Duchesneau, Andrew J. Fishleder, Lisa R. Rogers, Jeannine Alexander and C Nuñez and has published in prestigious journals such as Neurology, Cancer and The Journal of Urology.

In The Last Decade

L. Bauer

10 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Bauer United States	8	145	82	71	53	46	10	251
Michael Fusco United States	9	97 0.7×	63 0.8×	109 1.5×	73 1.4×	30 0.7×	17	308
Hilda Haynes United States	11	207 1.4×	82 1.0×	37 0.5×	128 2.4×	12 0.3×	21	384
Zdeněk Mechl Hungary	10	159 1.1×	28 0.3×	71 1.0×	76 1.4×	13 0.3×	42	255
Alessandra Jales United States	6	137 0.9×	42 0.5×	144 2.0×	118 2.2×	44 1.0×	6	329
Nicholas Coupe United Kingdom	7	139 1.0×	43 0.5×	60 0.8×	72 1.4×	16 0.3×	19	220
M Meldrum United Kingdom	8	167 1.2×	43 0.5×	28 0.4×	152 2.9×	55 1.2×	9	371
Douglas K. Marks United States	11	184 1.3×	64 0.8×	71 1.0×	99 1.9×	16 0.3×	26	302
Wolfgang Moersig Germany	7	336 2.3×	87 1.1×	251 3.5×	60 1.1×	12 0.3×	12	432
Donald Gravenor United States	9	214 1.5×	52 0.6×	174 2.5×	150 2.8×	20 0.4×	24	433
Clay M. Anderson United States	9	134 0.9×	73 0.9×	48 0.7×	98 1.8×	8 0.2×	13	296

Countries citing papers authored by L. Bauer

Since Specialization

Citations

This map shows the geographic impact of L. Bauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Bauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Bauer more than expected).

Fields of papers citing papers by L. Bauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Bauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Bauer. The network helps show where L. Bauer may publish in the future.

Co-authorship network of co-authors of L. Bauer

This figure shows the co-authorship network connecting the top 25 collaborators of L. Bauer. A scholar is included among the top collaborators of L. Bauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Bauer. L. Bauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Budd, G. Thomas, Ram Ganapathi, L. Bauer, et al.. (1993). Phase I study of WR-2721 and carboplatin. European Journal of Cancer. 29(8). 1122–1127. 23 indexed citations

2.

Budd, G. Thomas, et al.. (1993). Phase II trial of doxorubicin and trifluoperazine in metastatic breast cancer. Investigational New Drugs. 11(1). 75–79. 17 indexed citations

3.

Bukowski, Ronald M., Denise McLain, James H. Finke, et al.. (1993). Phase I Trial of Recombinant Granulocyte-Macrophage Colony-Stimulating Factor in Patients with Lung Cancer: Clinical and Immunologic Effects. Journal of Immunotherapy. 13(4). 267–274. 15 indexed citations

4.

Bukowski, Ronald M., et al.. (1992). A phase I trial of 5-fluorouracil, folinic acid, and alpha-2a-interferon in patients with metastatic colorectal carcinoma. Cancer. 69(4). 889–892. 15 indexed citations

5.

Rogers, Lisa R., P M Duchesneau, C Nuñez, et al.. (1992). Comparison of cisternal and lumbar CSF examination in leptomeningeal metastasis. Neurology. 42(6). 1239–1239. 58 indexed citations

6.

Chéchile, G, Eric A. Klein, L. Bauer, Andrew C. Novick, & James E. Montie. (1992). Functional Equivalence of End and Loop Ileal Conduit Stomas. The Journal of Urology. 147(3 Part 1). 582–586. 4 indexed citations

7.

Bukowski, Ronald M., J. Sergi, G. Thomas Budd, et al.. (1991). Phase I Trial of Continuous Infusion Interleukin-2 and Doxorubicin in Patients with Refractory Malignancies. Journal of Immunotherapy. 10(6). 432–439. 5 indexed citations

8.

Bukowski, Ronald M., J. Sergi, G. Thomas Budd, et al.. (1991). Phase I trial of natural human interferon beta in metastatic malignancy.. PubMed. 51(3). 836–40. 7 indexed citations

9.

Bukowski, Ronald M., Patricia Rayman, Raymond Tubbs, et al.. (1991). Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma.. PubMed. 51(16). 4199–205. 80 indexed citations

10.

Budd, G. Thomas, A. P. Jayaraj, David J. Adelstein, et al.. (1990). Phase I trial of dipyridamole with 5-fluorouracil and folinic acid.. PubMed. 50(22). 7206–11. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact